SEARCH

SEARCH BY CITATION

References

  • 1
    Denninger MH, Beldjord K, Durand F, Denie C, Valla D, Guillin MC. Budd-Chiari syndrome and factor V Leiden mutation. Lancet 1995; 345: 525526.
  • 2
    Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. HEPATOLOGY 2000; 31: 587591.
  • 3
    Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38: 364371.
  • 4
    Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, et al. Factor V leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with budd-chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 23642368.
  • 5
    Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. HEPATOLOGY 2004; 39: 500508.
  • 6
    Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. HEPATOLOGY 1999; 30: 8489.
  • 7
    Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999; 44: 568574.
  • 8
    Valla D, Hadengue A, el Younsi M, Azar N, Zeitoun G, Boudet MJ, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. HEPATOLOGY 1997; 25: 814819.
  • 9
    Prandi D, Rueff B, Benhamou JP. Side-to-side portacaval shunt in the treatment of Budd-Chiari syndrome. Gastroenterology 1975; 68: 137141.
  • 10
    Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003; 39: 496501.
  • 11
    Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J Hepatol 2003; 38: 751754.
  • 12
    Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. HEPATOLOGY 2002; 35: 132139.
  • 13
    Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004; 135: 394403.
  • 14
    European Liver Transplant Association. European liver transplant registry. Data analysis 05/1968-12/1996. Villejuif, France: Hôpital Paul Brousse, 1997.
  • 15
    Hastings GS, O'Connor DK, Pais SO. Transjugular intrahepatic portosystemic shunt placement as a bridge to liver transplantation in fulminant Budd-Chiari syndrome. J Vasc Interv Radiol 1996; 7: 616.
  • 16
    Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996; 171: 176180; discussion 180–181.
  • 17
    Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992; 174: 453459.
  • 18
    Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. HEPATOLOGY 1995; 21: 13371344.
  • 19
    Burke A HZ, Furth EE, Lucey MR. Treatment of Budd-chiari syndrome (BCS) by transjugular intrahepatic portosystemic shunt. HEPATOLOGY 1996; 24: 491A.
  • 20
    Garcia-Pagan JC, Feu F, C B, Escorsell A, JC B, Luca A, et al. TIPS in the treatment of the Budd-Chiari syndrome [Abstract]. J Hepatol 1995; 23: 112.
  • 21
    Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994; 106: 10421047.
  • 22
    Huber MS, Haag Kochs A, Deibert P, Blum HE, Rossle M. The Budd-Chiari syndrome: long term results after treatment with the transjugular intrahepatic portosystemic shunt [Abstract]. HEPATOLOGY 1997; 26: 204A.
  • 23
    Zeitoun G, Azar N, El Younsi M, Escolano S, Mallet A, Hadengue A, et al. Does surgery influence the prognosis of Budd-Chiari syndrome? A multivariate retrospective analysis [Abstract]. HEPATOLOGY 1995: 144A.
  • 24
    Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001; 48: 264268.
  • 25
    Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, et al. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut 2001; 48: 849852.
  • 26
    O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273275.
  • 27
    de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167176.
  • 28
    Gupta S, Blumgart LH, Hodgson HJ. Budd-Chiari syndrome: long-term survival and factors affecting mortality. Q J Med 1986; 60: 781791.
  • 29
    Mitchell MC, Boitnott JK, Kaufman S, Cameron JL, Maddrey WC. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) 1982; 61: 199218.
  • 30
    Powell-Jackson PR, Melia W, Canalese J, Pickford RB, Portmann B, Williams R. Budd-Chiari Syndrome: clinical patterns and therapy. Q J Med 1982; 51: 7988.
  • 31
    Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WCJ, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001; 35: 338343.
  • 32
    Tavill AS, Wood EJ, Kreel L, Jones EA, Gregory M, Sherlock S. The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology 1975; 68: 509518.
  • 33
    Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55: 878884.
  • 34
    Warkentin TE. Heparin-induced thrombocytopenia and vascular surgery. Acta Chir Belg 2004; 104: 257265.
  • 35
    Warkentin TE. An overview of the heparin-induced thrombocytopenia syndrome. Semin Thromb Hemost 2004; 30: 273283.
  • 36
    Warkentin TE. Heparin-induced thrombocytopenia. Dis Mon 2005; 51: 141149.
  • 37
    Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005; 127: 35S45S.
  • 38
    Zhang CQ, Fu LN, Xu L, Zhang GQ, Jia T, Liu JY, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol 2003; 9: 25872591.
  • 39
    Valla D, Dhumeaux D, Babany G, Hillon P, Rueff B, Rochant H, et al. Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria: a spectrum from asymptomatic occlusion of hepatic venules to fatal Budd- Chiari syndrome. Gastroenterology 1987; 93: 569575.
  • 40
    Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. HEPATOLOGY 2004; 40: 11971202.
  • 41
    Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996; 25: 135144.
  • 42
    Cazals-Hatem D, Vilgrain V, Genin P, Denninger MH, Durand F, Belghiti J, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. HEPATOLOGY 2003; 37: 510519.
  • 43
    Bahr MJ, Schubert J, Bleck JS, Tietge UJ, Boozari B, Schmidt RE, et al. Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria. Transpl Int 2003; 16: 890894.
  • 44
    Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002; 73: 973977.
  • 45
    Schattenfroh N, Bechstein WO, Blumhardt G, Langer R, Lobeck H, Langrehr JM, et al. Liver transplantation for PNH with Budd-Chiari syndrome: a case report. Transpl Int 1993; 6: 354358.
  • 46
    Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001; 35: 338343.